BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

Wyeth LRRK2 Pages on BioPortfolio:

BioPortfolio - lrrk2 2008
Wyeth LRRK2 - BioPortfolio. ... Neuroscience Discovery Research Wyeth Research Princeton New Jersey J Neurosci 2008 Jul 2282767579 DOI Direct Link Re LRRK2 ...
http://www.bioportfolio.com/search/lrrk2_2008.html...

BioPortfolio - united gene holdings
Advanced Life Sciences Holdings Inc. (ADLS) and Wyeth (WYE) Collaborate to . ... BACKGROUND: Mutations in the LRRK2 gene are an important cause of familial ...
http://www.bioportfolio.com/search/_united_gene_holdings_.ht...

Results from other life science and pharmaceutical sites:

The Michael J. Fox Foundation Awards $4.6 Million To 10 Industry ...
... PhD Wyeth Research (Princeton, New Jersey) LRRK2: Accelerated Pre-Clinical Development of a Novel Disease-modifying Therapeutic for Parkinson's Disease ...
http://www.biospace.com/news_story.aspx?NewsEntityId=43419...

Heat shock protein 90 modulates LRRK2 stability: potential ...
Neuroscience Discovery Research, Wyeth Research, Princeton, New Jersey 08543, ... Neurotoxins; LRRK2 protein, human; Protein-Serine-Threonine Kinases ...
http://www.ncbi.nlm.nih.gov/pubmed/18596151...

The Michael J. Fox Foundation for Parkinson's Research - Research ...
Institution: Wyeth Research MJFF Program: Therapeutics Development Initiative 2006. grant abstract · view researcher bio · LRRK2 and Parkinson's Genetic ...
http://www.michaeljfox.org/research_MJFFfundingPortfolio_sea...

12 selected items - PubMed Results
Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's ... Neuroscience Discovery Research, Wyeth Research, Princeton, ...
http://www.ncbi.nlm.nih.gov/pubmed/18590728,18250955,1858686...

The Michael J. Fox Foundation for Parkinson's Research - News and ...
... goals within the Wyeth Neuroscience group,” said awardee Peter Reinhart, ... Reinhart seeks to develop drugs to inhibit the PD-implicated gene LRRK2. ...
http://www.michaeljfox.org/newsEvents_mjffInTheNews_article....

Patent alert
in collaboration with Wyeth, and appears to be the first. filing in this area for the company. ... A leucine-rich repeat kinase 2 (LRRK2) modulating agent ...
http://www.biomedcentral.com/content/pdf/cd-870607.pdf...

New Alzheimer’s Vaccine Trial New CCRC Affiliations for the BU ADC
In an earlier trial by Elan-Wyeth, mild to moderate ..... tions of LRRK2 with pathways linked to protein fold-. ing and degradation. Goodbyes ...
http://www.bu.edu/alzresearch/documents/bu-adc-bulletin-fall...

The Michael J. Fox Foundation for Parkinson's Research - Research ...
Supplemental Grant of Park8 Mouse Models and LRRK2 Kinase Substrates ...... Institution: Wyeth Research MJFF Program: Therapeutics Development Initiative
...
http://www.michaeljfox.org/research_MJFFfundingPortfolio_sea...

DEPARTMENT OF NEUROLOGY ANNUAL REPORT 2004
Wyeth-Ayerst Laboratories. Foundations. Charles F Yeager Foundation, Inc. ...... Genetic screening for a single common LRRK2 mutation in familial ...
http://www.med.wayne.edu/Neurology/pdf/2004AnnualReport.pdf...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.